Navigation Links
Metal stents are effective treatment for blocked bile ducts
Date:3/20/2013

ign biliary strictures, but it's associated with significant complications and mortality. Today, minimally invasive endoscopic stent placement has emerged as a less invasive and more successful therapeutic option.

Only permanent plastic stents are currently FDA approved for benign stricture indications. However, these plastic stents involve multiple endoscopic procedures and multiple large stents. Also, plastic stents are often associated with stent blockages and failure of long-term durable results for stricture resolution.

FCSEMS are being tested in patients with benign biliary strictures to overcome the limitations of plastic stents, and the complications of their uncovered or semi-covered metal stent counterparts. The fully covered membrane design of FCSEMS prevents embedding and ingrowth of the stent into the bile duct's wall.

The research study examined 133 patient cases performed between April 2009 and October 2010 at six centers. Each patient received a FCSEMS during an endoscopic stenting procedure to open his or her severely narrowed or blocked benign bile duct stricture and restore bile flow. A 40, 60 or 80 millimeter length metal stent was implanted via a thin catheter to the blockage site over a guide wire. The stent was then partially deployed and pulled against the stricture prior to full deployment. These temporary metal stents were implanted all in one endoscopic procedure and removed after an average of three months.

This study is the first to analyze the safety and efficiency of these implanted metal stents for benign stricture resolution after their removal. "The study showed the majority of patients who received a metal stent had symptom relief, negative imaging for stricture and no need for repeat stent replacement except the patients who underwent liver transplant," says Dr. Kahaleh.

Stricture resolution after FCSEMS removal was 91.6 percent successful in post-surgical cases, 84.2 percent in gall
'/>"/>

Contact: Lauren Woods
Law2014@med.cornell.edu
646-317-7401
Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. MRI may predict adverse tissue reaction in metal-on-metal hip replacement patients
2. Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding Increased Metal Ion Levels May Predict Problems with Metal-on-Metal Hip Replacements
3. Higher levels of several toxic metals found in children with autism
4. US Drug Watchdog Is Now Urging Recipients Of A Recalled DePuy ASR Metal on Metal Hip Implant To Call Them If They Do Not Have A Law Firm-Before Time Could Run Out
5. US Drug Watchdog Now Urges Recalled DePuy ASR All Metal Hip Implant Recipients To Call Them For The Names Of The Best Law Firms And To Get Identified-Before Time Runs Out
6. US Drug Watchdog Now Urges All Metal Hip Implant Recipients Who Have Had Revision Surgeries To Call Them For The Names of Attorneys To Help Them Get Compensated
7. US Drug Watchdog Now Offers To Try To Help All Recalled DePuy ASR All Metal Hip Implant Recipients Get Identified To The Best Possible Attorneys-Get Compensated
8. Los Angeles Personal Injury Attorney Jeff Nadrich Responds to News that Johnson & Johnson Inadequately Assessed Metal Hip Dangers
9. The Precision Metalforming Association Strengthens Partnership with Succeed Management Solutions, LLC to Help Members Improve Industry Safety and Compliance
10. US Drug Watchdog Now Urges All DePuy ASR And Pinnacle All Metal Hip Implant Recipients To Get A Blood Test And To Call Them Before The Time Runs Out To Get Identified
11. Rare Earth Metals Market - New Industry Research Report is Now Available for Pre Order at Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... CA (PRWEB) March 05, 2015 A Bakersfield, ... a seven-week trial awarding the plaintiff Coleen M. ... as a result of a TVT-Abbrevo pelvic mesh sling device, ... , Tom Cartmell , a partner at Wagstaff ... trial team for the plaintiff, along with Rich Freese and ...
(Date:3/5/2015)... March 05, 2015 Risperdal lawsuits ... a Pennsylvania mass tort litigation currently underway in ... jury has begun hearing testimony in the proceeding’s ... antipsychotic medication can cause gynecomastia, or male breast ... question was filed on behalf of a plaintiff ...
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased to ... new logo and optimized website. , CNI’s ... to expert diagnostic imaging, centered on patient care. The ... be a resource for Nebraska patients and a tool ... and referral functionality, video content and resources to understand ...
(Date:3/5/2015)... HomeCEUConnection.com is proud to support Nutrition ... their nutrition CEUs. To raise awareness on ... is offering 10% off selected nutrition CEU ... . , High Quality Continuing Education for ... continuing education courses for Physical Therapists, Physical ...
(Date:3/5/2015)... Angeles, CA (PRWEB) March 05, 2015 ... article titled “Butt Augmentation, Labiaplasty on the Rise, Plastic ... reported by the American Society for Aesthetic Plastic ... Surgeons . Both groups reported a year-over-year doubling of ... of the physicians quoted in the article, this increase ...
Breaking Medicine News(10 mins):Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2
... FORT WORTH, Texas, June 15 Female caregivers of African American ... papillomavirus (HPV), according to a new study by the Center for ... Worth, Texas. , , The HPV Vaccine Acceptability Study discovered ... , Most ...
... thread, researcher says , MONDAY, June 15 (HealthDay News) ... major cardiovascular disease and death, a new study finds. ... Administration medical facility study to compare 3,236 people suffering ... a 78 percent higher incidence of heart disease, a ...
... , WASHINGTON, June 15 Just as Congress begins to ... since Medicare became law in 1965, Hudson Institute will debate ... 17th. , , Health costs will define the long-term ... care costs will be the topic of the Hudson panel. ...
... Va., June 15 Escalating funding issues challenge social ... across the country indicate that decreasing funds impact both ... state governments face new budget years a stark reality ... that provide minimal, but essential, services to the country,s ...
... New Pharmacy Benefit Evaluator Analyzes Health Plan Pharmacy Benefit ... Care Sales Strategy Development , , NASHVILLE, Tenn., ... care market intelligence, has enhanced its Pharmacy ... health plan pharmacy benefit structure and spending and the ...
... special interest," says campaign finance watchdog group , ... has spent $204.4 million to influence Congress and Administrations over ... contributions over the last two decades, according to a Public ... Responsive Politics website. , , "When President Obama addresses ...
Cached Medicine News:Health News:HPV Vaccine Acceptability Study Announces Results 2Health News:HPV Vaccine Acceptability Study Announces Results 3Health News:Psoriasis Raises Risk of Heart Attack, Stroke, Death 2Health News:Hudson Institute Debates the Long-Term Fiscal Impact of Health Care Reform 2Health News:Government Must Not Balance Budget on the Backs of the Poor 2Health News:Government Must Not Balance Budget on the Backs of the Poor 3Health News:HealthLeaders-InterStudy Launches Pharmacy Benefit Evaluator 2Health News:Backgrounder: As Obama Makes Pitch to AMA, the Group Tries to Call in its Political Investment in Congress 2
(Date:3/5/2015)... ALBANY, N.Y. , March 5, 2015  AMRI ... Michael Pettersson , fills the newly created position of ... Christopher Conway , Senior Vice President of Global ... Mr. Pettersson will lead the international sales team in ... market share in targeted market segments. Mr. Pettersson will ...
(Date:3/5/2015)... - Cross reference: Picture is ... - Hitachi Medical Systems Europe è ... OASIS* all,ECR 2015. Si tratta di un sistema ... T che migliora la capacità diagnostica dei sistemi già ... del paziente. Le nuove funzionalità di OASIS permettono una ...
(Date:3/5/2015)... PRINCETON, N.J. , March 5, 2015 ... late stage biopharmaceutical company committed to developing products that ... oncology and biodefense, announced today that its President and ... will give a corporate presentation at the 27 th ... California , on Tuesday, March 10, 2015 at ...
Breaking Medicine Technology:AMRI Hires VP of International Sales 2Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 2Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 3Hitachi Medical Systems Europe lancia la nuova generazione di OASIS*: Il sistema di RM aperta ad alto campo da 1.2 T. Ancora più valore al paziente 4Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3
... median survival vs. ... parallel external controls -, IRVINE, Calif., Nov. 2 ... from the Phase 2 study of,its investigational agent IDM-2101 which showed ... responses,and showed a positive survival trend in patients with non-small cell ...
... In a move to improve,significantly the safety ... emergency medical information service, has joined,the Alzheimer,s Association ... offer MedicAlert(R) + Safe Return(R). Currently, there are ... almost 10 million,people caring for someone with Alzheimer,s ...
Cached Medicine Technology:IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients 2IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients 3IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients 4MedicAlert Foundation Joins The Alzheimer's Association to Offer MedicAlert(R) + Alzheimer's Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies 2MedicAlert Foundation Joins The Alzheimer's Association to Offer MedicAlert(R) + Alzheimer's Association Safe Return(R) - Live 24-Hour Emergency Response for Wandering and Medical Emergencies 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: